Randomized controlled trial to compare oral iron to parenteral iron therapy for correction of iron deficiency in chronic kidney disease.
- Conditions
- Health Condition 1: D508- Other iron deficiency anemias
- Registration Number
- CTRI/2020/04/024881
- Lead Sponsor
- Dr Manu Dogra
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Iron deficiency defined as TSAT < 30 % and serum ferritin < 500mg/dL
2. Clinically stable course for last 3 months
1.Blood hemoglobin < 9 g/dl
2.Current use or use within last 3 months of oral or intravenous iron preparations
3.Known / suspected diagnosis of autoimmune disease
4.Past or present diagnosis of malignancy
5.Known diagnosis of chronic liver disease
6.History of any bleeding diathesis
7.History of gastro-intestinal surgery
8.Present or past diagnosis of peptic ulcer disease, gastro-intestinal bleeding or any form of gastro-intestinal disease predisposing to malabsorption
9.Currently taking gastric acid inhibitors (H2 receptor blockers, proton pump inhibitors)
10.History of allergic reactions to any form of oral or intravenous iron preparations
11.History of prior non-compliance with oral iron therapy due to gastro-intestinal side effects
12.Current use or use within last 6 months of immunosuppressive drug therapy
13.Pregnancy or lactation, in case of females
14.Life expectancy < 1 year
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method